Stephen J Mcandrew - Net Worth and Insider Trading

Stephen J Mcandrew Net Worth

The estimated net worth of Stephen J Mcandrew is at least $1,994 dollars as of 2024-11-13. Stephen J Mcandrew is the SVP Bus. Strat. & Dev. of Outlook Therapeutics Inc and owns about 318 shares of Outlook Therapeutics Inc (OTLK) stock worth over $1,994. Details can be seen in Stephen J Mcandrew's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen J Mcandrew has not made any transactions after 2017-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephen J Mcandrew

To

Stephen J Mcandrew Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen J Mcandrew owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .

Click here to see the complete history of Stephen J Mcandrew’s form 4 insider trades.

Insider Ownership Summary of Stephen J Mcandrew

Ticker Comapny Transaction Date Type of Owner
OTLK Outlook Therapeutics Inc 2017-12-22 SVP Bus. Strat. & Dev.

Stephen J Mcandrew Latest Holdings Summary

Stephen J Mcandrew currently owns a total of 1 stock. Stephen J Mcandrew owns 318 shares of Outlook Therapeutics Inc (OTLK) as of December 22, 2017, with a value of $1,994.

Latest Holdings of Stephen J Mcandrew

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLK Outlook Therapeutics Inc 2017-12-22 318 6.27 1,994

Holding Weightings of Stephen J Mcandrew


Stephen J Mcandrew Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen J Mcandrew has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 98 shares on December 22, 2017, which brought Stephen J Mcandrew around $17,747.

Insider Trading History of Stephen J Mcandrew

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen J Mcandrew Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen J Mcandrew Ownership Network

Ownership Network List of Stephen J Mcandrew

No Data

Ownership Network Relation of Stephen J Mcandrew

Insider Network Chart

Stephen J Mcandrew Owned Company Details

What does Outlook Therapeutics Inc do?

Who are the key executives at Outlook Therapeutics Inc?

Stephen J Mcandrew is the SVP Bus. Strat. & Dev. of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .

Outlook Therapeutics Inc (OTLK) Insider Trades Summary

Over the past 18 months, Stephen J Mcandrew made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outlook Therapeutics Inc Insider Transactions

No Available Data

Stephen J Mcandrew Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen J Mcandrew. You might contact Stephen J Mcandrew via mailing address: 8800 Technology Forest Place, Woodlands Tx 77381.